CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bioqual Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bioqual Inc
9600 Medical Center Drive, Suite 101
Phone: (240) 404-7654p:240 404-7654 ROCKVILLE, MD  20850-3336  United States Ticker: BIOQBIOQ
This company no longer files statements with the SEC.
Business Summary
BIOQUAL, Inc. provides contract research services primarily focused on animal models of human diseases including acquired immunodeficiency syndrome (AIDS), influenza, respiratory syncytial virus (RSV) infection, coronavirus infections (including COVID-19), flavivirus infections (including Zika and Dengue), malaria, hepatitis, cancer, and other infectious diseases. It also performs in vitro contract research services. It is involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. Its services also encompass sample processing and custom assays for serology, cell-mediated immunity, viral loads, and bacterial enumeration. Its model services also include syngeneic mouse tumor allograft and select human cell line derived xenograft (CDX) models, and it offers GLP-compliant preclinical testing services in various small animal models. It provides its services to the federal government, universities and the life science and pharmaceutical industries.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
11/30/20245/31/2023YesYes---

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer Mark G.Lewis 4/19/2017 1/1/2015
Chief Financial Officer Charles C.Kirk 6/3/2022 6/3/2022
Chief Scientific Officer Hanne A.Elyard 5/9/2022 5/9/2022
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 108 (As of 5/31/2001)
Outstanding Shares: 894,416 (As of 11/30/2024)
Shareholders: 1,000
Stock Exchange: OTC
Federal Tax Id: 133078199
Fax Number: (240) 404-7664


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, January 29, 2025